Suche klinische Studie
Weitere Suchoptionen
7 Ergebnis(se)
Rekrutierende Studie = 
; Fortlaufende Studie = 
; Abgeschlossene Studie = 
; Förderung durch ein IRDiRC-Mitglied = 
; Studie unter Beteiligung von ERN-Mitgliedern aus mindestens zwei Mitgliedstaaten = 
Nationale klinische Studie(n)
SPANIEN
Cataluña
BARCELONA
Clinical trial to evaluate safety and efficacy of rapamycin in angiomyolipomas of patients with tuberosclerosis - ES (completed)
Fundació Puigvert
Servicio de Nefrología
SPANIEN
Cataluña
BARCELONA
A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and pharmacodynamics of AT1001 in patients with Fabry disease and AT1001-responsive GLA mutations - ES (completed)
Fundació Puigvert
Servicio de Nefrología
SPANIEN
Cataluña
BARCELONA
EXIST-2: A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) - ES (Completed)
Fundació Puigvert
Servicio de Nefrología
SPANIEN
Cataluña
BARCELONA
An open-label, multi-center, expanded access study of RAD001 in patients with angiomyolipoma associated with tuberous sclerosis complex (TSC) - ES (Completed)
Fundació Puigvert
Servicio de Nefrología
SPANIEN
Cataluña
BARCELONA
An Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of Migalastat Hydrochloride Monotherapy in subjects with Fabry Disease - ES (Completed)
Fundació Puigvert
Servicio de Nefrología
SPANIEN
Cataluña
BARCELONA
STAGED-PKD: Multicenter, Randomized, Double-blind, Placebo-controlled Two Stage Study to Characterize the Efficacy, Safety, Tolerability and Pharmacokinetics of GZ/SAR402671 in Patients at Risk of Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) - ES (completed)
Fundació Puigvert
Servicio de Nefrología
SPANIEN
Cataluña
BARCELONA